Literature DB >> 27857995

Anaphylaxis after intravenous infusion of dexketoprofen trometamol.

Sertac Guler1, Ilyas Ertok1, Nurdan Yilmaz Sahin1, Hayri Ramadan1, Yavuz Katirci1.   

Abstract

Dexketoprofen trometamol (DT), a nonsteroidal anti-inflammatory drug, is a highly water-soluble salt and active enantiomer of rac-ketoprofen. Its parenteral form is commonly used for acute pain management in emergency departments of our country. Side effects such as diarrhea, indigestion, nausea, stomach pain, and vomiting may be seen after the use of DT. Anaphylactic shock (AS) secondary to infusion of DT is very rare and, to our knowledge, it is the first case report describing this side effect. This case report was presented to emphasize that AS may be seen after the use of DT.

Entities:  

Keywords:  Anaphylactic shock; Dexketoprofen trometamol; Intravenous infusion (MeSH database)

Year:  2016        PMID: 27857995      PMCID: PMC5103062          DOI: 10.1016/j.tjem.2016.09.003

Source DB:  PubMed          Journal:  Turk J Emerg Med        ISSN: 2452-2473


  11 in total

1.  Comparing the efficacy of intravenous tenoxicam, lornoxicam, and dexketoprofen trometamol for the treatment of renal colic.

Authors:  Erdem Cevik; Orhan Cinar; Necati Salman; Aytekin Bayir; Ibrahim Arziman; Sukru Ardic; Scott Travis Youngquist
Journal:  Am J Emerg Med       Date:  2012-02-04       Impact factor: 2.469

2.  Clinical pharmacokinetics of parenteral dexketoprofen trometamol in healthy subjects.

Authors:  J Valles; R Artigas; A Crea; F Muller; I Paredes; A Zapata; A Capriati
Journal:  Methods Find Exp Clin Pharmacol       Date:  2006-06

3.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

4.  Intravenous paracetamol versus dexketoprofen in acute migraine attack in the emergency department: a randomised clinical trial.

Authors:  Ibrahim Turkcuer; Mustafa Serinken; Cenker Eken; Atakan Yilmaz; Ömer Akdag; Emrah Uyan; Cihan Kiray; Hayri Elicabuk
Journal:  Emerg Med J       Date:  2014-01-06       Impact factor: 2.740

5.  Single-dose-dexketoprofen-induced acute kidney injury due to massive rhabdomyolysis.

Authors:  Tansu Sav; Aydin Unal; Abdulsamet Erden; Ali Ihsan Gunal
Journal:  Int Urol Nephrol       Date:  2011-05-07       Impact factor: 2.370

6.  Comparison of the efficacy and tolerability of dexketoprofen and ketoprofen in the treatment of primary dysmenorrhea.

Authors:  M Ezcurdia; F J Cortejoso; R Lanzón; F J Ugalde; A Herruzo; R Artigas; F Fernández; F Torres; D Mauleón
Journal:  J Clin Pharmacol       Date:  1998-12       Impact factor: 3.126

7.  Neutropenia, thrombocytopenia and hepatic injury associated with dexketoprofen trometamol therapy in a previously healthy 35-year-old woman.

Authors:  S Zabala; M J Calpe; G Pérez; F J Lerín; L Mouronval
Journal:  J Clin Pharm Ther       Date:  2008-02       Impact factor: 2.512

8.  Comparison of the analgesic efficacy of dexketoprofen trometamol and meperidine HCl in the relief of renal colic.

Authors:  Mehmet Oguzhan Ay; Ahmet Sebe; Nalan Kozaci; Salim Satar; Ayca Acikalin; Muge Gulen; Selen Acehan
Journal:  Am J Ther       Date:  2014 Jul-Aug       Impact factor: 2.688

9.  Randomised controlled trial of the onset of analgesic efficacy of dexketoprofen and diclofenac in lower limb injury.

Authors:  P Leman; Y Kapadia; J Herington
Journal:  Emerg Med J       Date:  2003-11       Impact factor: 2.740

10.  World allergy organization guidelines for the assessment and management of anaphylaxis.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Yehia M El-Gamal; Dennis K Ledford; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong
Journal:  World Allergy Organ J       Date:  2011-02-23       Impact factor: 4.084

View more
  1 in total

Review 1.  Immediate hypersensitivity to COVID-19 vaccines: Focus on biological diagnosis.

Authors:  Pascale Nicaise-Roland; Vanessa Granger; Angèle Soria; Annick Barbaud; Marc Pallardy; Sylvie Chollet-Martin; Luc de Chaisemartin
Journal:  Front Allergy       Date:  2022-09-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.